Q1 2026 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | 6.4% increase | Total Revenue increased from $3,975 million in Q1 2025 to $4,228 million in Q1 2026, driven by broad-based segment improvements. This growth builds on earlier period trends—where segments such as Health & Civil and Commercial & International showed strong performance—which helped propel overall revenue higher. |
Health & Civil segment | 7.3% increase | The Health & Civil segment grew from $1,199 million in Q1 2025 to $1,286 million in Q1 2026. This increase is likely due to enhanced volumes and case complexity in managed health services, a trend observed in previous periods, which translated into higher revenues as programs matured. |
Commercial & International segment | 11.4% increase | The Commercial & International segment jumped from $509 million in Q1 2025 to $567 million in Q1 2026. This robust increase is attributed to stronger business activities, additional program wins, and improved geographic diversification, building on earlier successes that had been instrumental in previous period recoveries. |
Defense Systems segment | 7.2% increase | The Defense Systems segment increased from $474 million in Q1 2025 to $508 million in Q1 2026. The higher revenue reflects continued benefits from increased scope and new business awards, similar to trends noted in prior periods, though modestly impacted by persistent operational challenges. |
National Security & Digital segment | 4.1% increase | The National Security & Digital segment rose from $1,793 million in Q1 2025 to $1,867 million in Q1 2026. A moderate growth rate indicates steady performance improvements—such as enhanced program execution and incremental volumes—reflecting a mature segment building on previously established momentum. |
Research analysts covering Leidos Holdings.